1. An Insight into the Development of Potential Antidiabetic Agents along with their Therapeutic Targets
   Siddhita Tiwari et al, 2024, Endocrine, Metabolic & Immune Disorders - Drug Targets CrossRef
2. Interleukin‐32β ameliorates metabolic disorder and liver damage in mice fed high‐fat diet
   Dong Hun Lee et al, 2015, Obesity CrossRef
3. PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part I: PPAR-α
   Lu Han et al, 2017, Future Cardiology CrossRef
4. PPAR agonists reduce steatosis in oleic acid-overloaded HepaRG cells
   Alexandra Rogue et al, 2014, Toxicology and Applied Pharmacology CrossRef